• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高收入国家消除丙型肝炎病毒的进展:最新分析。

Progress towards hepatitis C virus elimination in high-income countries: An updated analysis.

机构信息

Center for Disease Analysis, Lafayette, LA, USA.

Hôpital Henri Mondor, Université Paris-Est, and INSERM U955, Créteil, France.

出版信息

Liver Int. 2021 Mar;41(3):456-463. doi: 10.1111/liv.14779. Epub 2021 Jan 19.

DOI:10.1111/liv.14779
PMID:33389788
Abstract

BACKGROUND & AIMS: Elimination of HCV by 2030, as defined by the World Health Organization (WHO), is attainable with the availability of highly efficacious therapies. This study reports progress made in the timing of HCV elimination in 45 high-income countries between 2017 and 2019.

METHODS

Disease progression models of HCV infection for each country were updated with latest data on chronic HCV prevalence, and annual diagnosis and treatment levels, assumed to remain constant in the future. Modelled outcomes were analysed to determine the year in which each country would meet the WHO 2030 elimination targets.

RESULTS

Of the 45 countries studied, 11 (Australia, Canada, France, Germany, Iceland, Italy, Japan, Spain, Sweden, Switzerland, and United Kingdom) are on track to meet WHO's elimination targets by 2030; five (Austria, Malta, Netherlands, New Zealand, and South Korea) by 2040; and two (Saudi Arabia and Taiwan) by 2050. The remaining 27 countries are not expected to achieve elimination before 2050. Compared to progress in 2017, South Korea is no longer on track to eliminate HCV by 2030, three (Canada, Germany, and Sweden) are now on track, and most countries (30) saw no change.

CONCLUSIONS

Assuming high-income countries will maintain current levels of diagnosis and treatment, only 24% are on track to eliminate HCV by 2030, and 60% are off track by at least 20 years. If current levels of diagnosis and treatment continue falling, achieving WHO's 2030 targets will be more challenging. With less than ten years remaining, screening and treatment expansion is crucial to meet WHO's HCV elimination targets.

摘要

背景与目的

世界卫生组织(WHO)定义的到 2030 年消除 HCV 是可以实现的,这需要高效疗法的应用。本研究报告了在 2017 年至 2019 年间,45 个高收入国家在 HCV 消除时间方面取得的进展。

方法

对每个国家的 HCV 感染疾病进展模型进行了更新,纳入了最新的慢性 HCV 流行率数据,以及未来假定保持不变的年度诊断和治疗水平。对模型结果进行分析,以确定每个国家将在哪一年达到 WHO 2030 年消除目标。

结果

在所研究的 45 个国家中,有 11 个(澳大利亚、加拿大、法国、德国、冰岛、意大利、日本、西班牙、瑞典、瑞士和英国)有望在 2030 年达到 WHO 的消除目标;5 个(奥地利、马耳他、荷兰、新西兰和韩国)有望在 2040 年达到目标;2 个(沙特阿拉伯和中国台湾地区)有望在 2050 年达到目标。其余 27 个国家预计在 2050 年前无法实现消除。与 2017 年的进展相比,韩国不再有望在 2030 年消除 HCV,有 3 个(加拿大、德国和瑞典)现在有望实现,大多数国家(30 个)没有变化。

结论

假设高收入国家将保持目前的诊断和治疗水平,只有 24%有望在 2030 年前消除 HCV,60%至少落后 20 年。如果目前的诊断和治疗水平继续下降,实现世卫组织的 2030 年目标将更加困难。距离实现目标仅剩不到十年时间,扩大筛查和治疗范围对于实现世卫组织的 HCV 消除目标至关重要。

相似文献

1
Progress towards hepatitis C virus elimination in high-income countries: An updated analysis.高收入国家消除丙型肝炎病毒的进展:最新分析。
Liver Int. 2021 Mar;41(3):456-463. doi: 10.1111/liv.14779. Epub 2021 Jan 19.
2
Global timing of hepatitis C virus elimination in high-income countries.高收入国家丙型肝炎病毒消除的全球时间表。
Liver Int. 2020 Mar;40(3):522-529. doi: 10.1111/liv.14324. Epub 2019 Dec 23.
3
Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study.直接作用抗病毒药物时代欧洲丙型肝炎负担和治疗趋势的变化:建模研究。
BMJ Open. 2019 Jun 11;9(6):e026726. doi: 10.1136/bmjopen-2018-026726.
4
Estimating the Year Each State in the United States Will Achieve the World Health Organization's Elimination Targets for Hepatitis C.估算美国各州实现世界卫生组织丙型肝炎消除目标的年份。
Adv Ther. 2021 Jan;38(1):423-440. doi: 10.1007/s12325-020-01535-3. Epub 2020 Nov 3.
5
Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020.模拟消除冰岛的丙型肝炎公共卫生威胁:2020 年可实现目标。
J Hepatol. 2018 May;68(5):932-939. doi: 10.1016/j.jhep.2017.12.013. Epub 2017 Dec 21.
6
Elimination of HCV in Russia: Barriers and Perspective.俄罗斯消除丙型肝炎病毒:障碍与展望。
Viruses. 2022 Apr 11;14(4):790. doi: 10.3390/v14040790.
7
Hepatitis C screening in Lithuania: first-year results and scenarios for achieving WHO elimination targets.立陶宛丙型肝炎筛查:第一年的结果及实现世界卫生组织消除目标的方案。
BMC Public Health. 2024 Apr 15;24(1):1055. doi: 10.1186/s12889-024-18470-5.
8
A tool to measure the impact of inaction toward elimination of hepatitis C: A case study in Korea.一种衡量对消除丙型肝炎不作为影响的工具:韩国案例研究。
PLoS One. 2020 Apr 28;15(4):e0232186. doi: 10.1371/journal.pone.0232186. eCollection 2020.
9
Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries.欧洲和欧亚国家丙型肝炎诊断和治疗方法的可及性。
Antiviral Res. 2018 Feb;150:9-14. doi: 10.1016/j.antiviral.2017.12.001. Epub 2017 Dec 5.
10
Global cascade of care for chronic hepatitis C virus infection: A systematic review and meta-analysis.全球慢性丙型肝炎病毒感染的治疗路径:一项系统评价和荟萃分析。
J Viral Hepat. 2021 Oct;28(10):1340-1354. doi: 10.1111/jvh.13574. Epub 2021 Jul 31.

引用本文的文献

1
Stakeholder perspectives and the challenges in implementing hepatitis C elimination policy in Pakistan.利益相关者的观点以及巴基斯坦实施丙型肝炎消除政策面临的挑战。
Front Public Health. 2025 Jul 16;13:1540689. doi: 10.3389/fpubh.2025.1540689. eCollection 2025.
2
Prevalence and risk factors of active hepatitis C infection among at-risk migrant populations in Madrid, Spain, 2019 to 2023.2019年至2023年西班牙马德里高危移民人群中丙型肝炎病毒活动性感染的患病率及危险因素
Euro Surveill. 2025 Jul;30(29). doi: 10.2807/1560-7917.ES.2025.30.29.2500150.
3
Simplified Treatment of Hepatitis C during the COVID-19 Pandemic: Retrospective Analysis of the British Columbia Hepatitis C Network.
新冠疫情期间丙型肝炎的简化治疗:不列颠哥伦比亚丙型肝炎网络的回顾性分析
Can Liver J. 2025 Feb 25;8(1):29-38. doi: 10.3138/canlivj-2024-0016. eCollection 2025 Feb.
4
Prioritising viral hepatitis elimination to prevent hepatocellular carcinoma: A public health approach for effective preventive hepatology.优先消除病毒性肝炎以预防肝细胞癌:有效预防肝病学的公共卫生方法。
JHEP Rep. 2025 May 2;7(8):101436. doi: 10.1016/j.jhepr.2025.101436. eCollection 2025 Aug.
5
Didactic Education on Viral Hepatitis Elimination within Medical School Curricula in the United States.美国医学院课程中关于消除病毒性肝炎的教学教育
Dig Dis Sci. 2025 Jun 11. doi: 10.1007/s10620-025-09111-x.
6
Prevalence-based screening by anti-HCV reflex HCV antigen test and accessible post-screening care towards elimination of hepatitis C in rural villages.通过抗丙型肝炎病毒(HCV)反射性HCV抗原检测进行基于患病率的筛查以及提供可及的筛查后护理以消除农村地区的丙型肝炎
BMC Gastroenterol. 2025 May 23;25(1):400. doi: 10.1186/s12876-025-03990-0.
7
Evaluating the effectiveness of a population-level health intervention to increment HCV treatment coverage in tuscany region, Italy: An interrupted time series analysis.评估一项旨在提高意大利托斯卡纳地区丙型肝炎病毒(HCV)治疗覆盖率的人群层面健康干预措施的有效性:一项中断时间序列分析。
PLoS One. 2025 May 16;20(5):e0306733. doi: 10.1371/journal.pone.0306733. eCollection 2025.
8
TeleHCV: A single-visit protocol and minimal passive remote monitoring are sufficient to achieve high SVR with a sofosbuvir-velpatasvir regimen.远程丙肝治疗:采用索磷布韦-维帕他韦方案时,单次就诊方案及最低限度的被动远程监测足以实现高持续病毒学应答率。
Clinics (Sao Paulo). 2025 Apr 23;80:100643. doi: 10.1016/j.clinsp.2025.100643. eCollection 2025.
9
Road to Hepatitis C Elimination in Israel: Improvements in Linkage to Care (2009-2020).以色列消除丙型肝炎之路:改善治疗衔接(2009 - 2020年)
Adv Ther. 2025 Mar;42(3):1522-1536. doi: 10.1007/s12325-024-03102-6. Epub 2025 Feb 6.
10
A novel multisite model to facilitate hepatitis C virus elimination in people experiencing homelessness.一种促进丙型肝炎病毒在无家可归者中消除的新型多站点模型。
JHEP Rep. 2024 Aug 12;6(11):101183. doi: 10.1016/j.jhepr.2024.101183. eCollection 2024 Nov.